Erratum: Activation of MAPK signaling by CXCR7 leads to enzalutamide resistance in prostate cancer (Cancer Research (2019) 79 (2580–2592) DOI: 10.1158/0008-5472.CAN-18-2812)

Shangze Li; Ka Wing Fong; Galina Gritsina; Ali Zhang; Jonathan C. Zhao; Jung Kim; Adam Sharp; Wei Yuan; Caterina Aversa; Ximing J. Yang; Peter S. Nelson; Felix Y. Feng; Arul M. Chinnaiyan; Johann S. de Bono; Colm Morrissey; Matthew B. Rettig; Jindan Yu

doi:10.1158/0008-5472.CAN-20-0768

Erratum: Activation of MAPK signaling by CXCR7 leads to enzalutamide resistance in prostate cancer (Cancer Research (2019) 79 (2580–2592) DOI: 10.1158/0008-5472.CAN-18-2812)

Shangze Li, Ka Wing Fong, Galina Gritsina, Ali Zhang, Jonathan C. Zhao, Jung Kim, Adam Sharp, Wei Yuan, Caterina Aversa, Ximing J. Yang, Peter S. Nelson, Felix Y. Feng, Arul M. Chinnaiyan, Johann S. de Bono, Colm Morrissey, Matthew B. Rettig, Jindan Yu

Research output: Contribution to journal › Comment/debate

Abstract

In the original version of this article (1), the same image was inadvertently duplicated in Fig. 5J, column #2. These errors have been corrected in the latest online HTML and PDF versions of the article. The authors regret this error.

Original language	English
Pages (from-to)	2072
Number of pages	1
Journal	Cancer Research
Volume	80
Issue number	10
DOIs	https://doi.org/10.1158/0008-5472.CAN-20-0768
State	Published - May 2020

Bibliographical note

Publisher Copyright:
© 2020 American Association for Cancer Research Inc.. All rights reserved.

ASJC Scopus subject areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1158/0008-5472.CAN-20-0768

Cite this

Li, S., Fong, K. W., Gritsina, G., Zhang, A., Zhao, J. C., Kim, J., Sharp, A., Yuan, W., Aversa, C., Yang, X. J., Nelson, P. S., Feng, F. Y., Chinnaiyan, A. M., de Bono, J. S., Morrissey, C., Rettig, M. B., & Yu, J. (2020). Erratum: Activation of MAPK signaling by CXCR7 leads to enzalutamide resistance in prostate cancer (Cancer Research (2019) 79 (2580–2592) DOI: 10.1158/0008-5472.CAN-18-2812). Cancer Research, 80(10), 2072. https://doi.org/10.1158/0008-5472.CAN-20-0768

@article{6a0700242ae84bb1806f4423f45772f2,

title = "Erratum: Activation of MAPK signaling by CXCR7 leads to enzalutamide resistance in prostate cancer (Cancer Research (2019) 79 (2580–2592) DOI: 10.1158/0008-5472.CAN-18-2812)",

abstract = "In the original version of this article (1), the same image was inadvertently duplicated in Fig. 5J, column #2. These errors have been corrected in the latest online HTML and PDF versions of the article. The authors regret this error.",

author = "Shangze Li and Fong, {Ka Wing} and Galina Gritsina and Ali Zhang and Zhao, {Jonathan C.} and Jung Kim and Adam Sharp and Wei Yuan and Caterina Aversa and Yang, {Ximing J.} and Nelson, {Peter S.} and Feng, {Felix Y.} and Chinnaiyan, {Arul M.} and {de Bono}, {Johann S.} and Colm Morrissey and Rettig, {Matthew B.} and Jindan Yu",

year = "2020",

month = may,

doi = "10.1158/0008-5472.CAN-20-0768",

language = "English",

volume = "80",

pages = "2072",

number = "10",

}

Li, S, Fong, KW, Gritsina, G, Zhang, A, Zhao, JC, Kim, J, Sharp, A, Yuan, W, Aversa, C, Yang, XJ, Nelson, PS, Feng, FY, Chinnaiyan, AM, de Bono, JS, Morrissey, C, Rettig, MB & Yu, J 2020, 'Erratum: Activation of MAPK signaling by CXCR7 leads to enzalutamide resistance in prostate cancer (Cancer Research (2019) 79 (2580–2592) DOI: 10.1158/0008-5472.CAN-18-2812)', Cancer Research, vol. 80, no. 10, pp. 2072. https://doi.org/10.1158/0008-5472.CAN-20-0768

TY - JOUR

T1 - Erratum

T2 - Activation of MAPK signaling by CXCR7 leads to enzalutamide resistance in prostate cancer (Cancer Research (2019) 79 (2580–2592) DOI: 10.1158/0008-5472.CAN-18-2812)

AU - Li, Shangze

AU - Fong, Ka Wing

AU - Gritsina, Galina

AU - Zhang, Ali

AU - Zhao, Jonathan C.

AU - Kim, Jung

AU - Sharp, Adam

AU - Yuan, Wei

AU - Aversa, Caterina

AU - Yang, Ximing J.

AU - Nelson, Peter S.

AU - Feng, Felix Y.

AU - Chinnaiyan, Arul M.

AU - de Bono, Johann S.

AU - Morrissey, Colm

AU - Rettig, Matthew B.

AU - Yu, Jindan

PY - 2020/5

Y1 - 2020/5

N2 - In the original version of this article (1), the same image was inadvertently duplicated in Fig. 5J, column #2. These errors have been corrected in the latest online HTML and PDF versions of the article. The authors regret this error.

AB - In the original version of this article (1), the same image was inadvertently duplicated in Fig. 5J, column #2. These errors have been corrected in the latest online HTML and PDF versions of the article. The authors regret this error.

UR - http://www.scopus.com/inward/record.url?scp=85084785861&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85084785861&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-20-0768

DO - 10.1158/0008-5472.CAN-20-0768

M3 - Comment/debate

C2 - 32414837

AN - SCOPUS:85084785861

VL - 80

SP - 2072

IS - 10

ER -

Erratum: Activation of MAPK signaling by CXCR7 leads to enzalutamide resistance in prostate cancer (Cancer Research (2019) 79 (2580–2592) DOI: 10.1158/0008-5472.CAN-18-2812)

Abstract

Bibliographical note

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this